-
Prescription Drug Expenditure Report Published
CP3 Faculty Affiliate Dr. Katie Suda is part of a team that publishes a yearly report on national prescription drug expenditure trends, as well as projections for the upcoming year.
Read the 2021 report here -
NASEM Report Release
Many expensive drugs are distributed in single-dose vials. What are implications of discarding the excess? CP3 Co-Director Dr. Julie Donohue was part of the NASEM committee to report the findings.
Read the report here -
Essien Receives Career Development Award
CP3 Faculty Affiliate Dr. Utibe Essien was received a 5-year VA HSR&D Career Development Award, "Access, Quality, & Equity in Anticoagulants in Veterans with Atrial Fibrillation." This award builds on Dr. Essien's previous research in this area.
Read more about Dr. Essien's work here -
Gellad Nominated to ASCI
CP3 Director Dr. Walid Gellad has been nominated to the American Society for Clinical Investigation (ASCI) for his contributions to academic medicine. Nominees were officially inducted on April 8, 2021.
See the list of nominees here
Improving the Quality, Safety and Efficiency of Medication Use
While prescription drugs are used by 80% of Americans, the improper, unsafe use of medications leads to billions of dollars of avoidable healthcare costs. The goal of the CP3 research program is to improve patient and prescriber decision-making, and inform the regulation and coverage of pharmaceuticals.
